Double-Digit Spike in Drug Costs Prescribes Profits for PBMs
A new report by employee benefit consultancy Aon Hewitt forecasts a 10% increase in employer drug costs through 2017, which puts a spotlight on pharmacy benefit management companies to assist employers, health plans, and government insurers such as Medicare and Medicaid to control prescription spending.
The Best Stock to Invest in Hep C
In the multibillion-dollar market for hepatitis C, this company stands above the crowd.
A New Drug Could Halt Weight Gain in Patients Taking These Antipsychotics
Alkermes Plc's ALKS 3831 could help patients that take atypical antidepressants avoid gaining weight.